Ashwin Sapra
Partner - Corporate, Life Sciences And Healthcare
Pharmaceuticals | Medical Devices | Nutraceuticals | Healthcare Services | Policy
Overview
Ashwin Sapra is widely regarded as one of India’s leading life sciences and healthcare lawyers, with over 25 years of experience advising on the most complex regulatory, transactional, and contentious matters in the sector. Ashwin is particularly recognised for his ability to navigate regulatory uncertainty and deliver commercially pragmatic solutions in a highly regulated and evolving sector that is often witness to disruptive policy changes.
He is a trusted advisor to multinational corporations, leading Indian companies, and healthcare delivery institutions on India’s regulatory regime governing pharmaceuticals, medical devices, diagnostics, nutraceuticals, health delivery services and related products. His expertise spans the full product lifecycle, including clinical trials, manufacturing, market entry, pricing/ price control, promotional practices, and post-market compliance.
Ashwin plays a central role in structuring and executing high-value M&A, private equity, business separation and capital markets transactions in a sector, where regulatory considerations are often determinative in cause and effect. He regularly leads regulatory due diligence activities and advises on approval frameworks and compliance risk in complex cross-border deals often involving strict global structures and timelines.
A seasoned litigator, Ashwin represents clients in high-stakes disputes involving product liability, regulatory enforcement, pricing actions, product recalls, and government procurement. He appears regularly before courts, tribunals, and sectoral regulators across India.
Known for his strategic, business-oriented approach, Ashwin advises clients on risk mitigation in the context of shifting legislative and policy landscapes, and is frequently engaged on matters involving ethical compliance, anti-bribery frameworks, and industry codes governing marketing and promotional activities.
He is also a recognised thought leader and a regular speaker on legal and policy developments in the healthcare and life sciences sector.
In addition to his extensive expertise in the healthcare sector, Ashwin is also the Honorary Counsel of Trust to the Austrian Embassy in India and advises on cross sectoral legal issues.
Education
- LL.M., Duke University School of Law
- LL.B., Symbiosis Law College, Pune
- B.Sc. (Hons) Zoology, University of Delhi
Admissions
- Admitted to practice in India; Member, Delhi High Court Bar Association
Select representative Matters
- Advised leading global pharmaceutical and medical device companies on the Indian legal and regulatory aspects of complex cross-border business separations and carve-outs, with a focus on aligning regulatory approvals and compliance timelines with global transaction milestones, identifying critical separation dependencies, and managing transitional arrangements essential to ensuring seamless business continuity.
- Advised global pharmaceutical and medical device companies on market entry and regulatory strategy in India, including pricing and commercialization frameworks.
- Advised a global pharmaceutical and medical device company on issues arising out of a global product recall and legality of regulatory action in product liability matters.
- Led regulatory due diligence and structuring for complex cross-border M&A and private equity investments in the healthcare and life sciences sector.
- Represented clients in high-stakes litigation involving drug price controls, product recalls, and regulatory enforcement actions.
- Advised on compliance frameworks relating to clinical trials, promotional practices, and interactions with healthcare professionals.
- Counselled leading healthcare providers on operational and regulatory compliance across multi-specialty hospital platforms.
Select representative clients
- Astrazeneca
- Baxter
- Corona Remedies
- Eli Lilly
- Fortis Hospitals
- Fresenius Medical Care
- Glenmark Pharmaceuticals
- GSK
- HCG Hospitals
- Intuitive Surgical
- Johnson & Johnson
- Max Healthcare
- MicroPort
- Pfizer
- Roche Diagnostics
- Sahrudaya Hospitals
- Stryker
- Vantive
- Zimmer Biomet
- Zydus Life Sciences
Recognition
- ‘Distinguished Practitioner’ for Pharmaceuticals and Life Sciences, Corporate and M&A – Asialaw Profiles 2026
- Chambers and Partners (Asia-Pacific): Band 2, 2022–2025
- India Business Law Journal: A-List Lawyer, 2024-2025
- Legal Era: Leading Lawyer Champion – Pharma & Healthcare, 2024-2025
- Legal 500: Leading Individual – Life Sciences & Healthcare, 2024
- Asia Law: Distinguished Practitioner, 2024
- IFLR1000: Highly Regarded, 2023
